Arrowhead Pharmaceuticals
ARWR
#2279
Rank
C$11.55 B
Marketcap
C$82.00
Share price
1.22%
Change (1 day)
46.64%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): C-$2.29

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$4.70. In 2022 the company made an earnings per share (EPS) of C-$2.06 an increase over its 2021 EPS that were of C-$2.48.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$2.2911.42%
2022C-$2.06-17.05%
2021C-$2.4874.26%
2020C-$1.42-283.64%
2019C$0.78-257.14%
2018C-$0.49-27.08%
2017C-$0.68-59.32%
2016C-$1.66-21.85%
2015C-$2.139.42%
2014C-$1.952.87%
2013C-$1.89-31.56%
2012C-$2.76300%
2011C-$0.69-45.56%
2010C-$1.27-66.67%
2009C-$3.81-63.51%
2008C-$10.43-12.94%
2007C-$11.9844.07%
2006C-$8.3277.35%
2005C-$4.6910.66%
2004C-$4.24-54.25%
2003C-$9.27-80.51%
2002C-$47.543.87%
2001C-$45.77116.17%
2000C-$21.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.43-300.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
C-$11.27 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$14.11-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$27.93-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
C-$2.58-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA